RCM
SCMP

Rotella Capital Management’s Sucampo Pharmaceuticals, Inc. SCMP Stock Holding History

Rotella Capital Management’s Portfolio SCMP Stock Details SCMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-16,798
Closed -$240K – 650
2014
Q4 		$240K Buy
+16,798
New +$177K 0.21% 109
2014
Q2 		– Sell
-10,495
Closed -$75K – 437
2014
Q1 		$75K Buy
+10,495
New +$89.8K 0.09% 134

Other funds holding SCMP

GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

Rotella Capital Management's SCMP Position: Q1 2015 in Review

Rotella Capital Management sold out of Sucampo Pharmaceuticals, Inc. (SCMP) in Q1 2015, closing a stake of 16,798 shares — an estimated $240K sold.

Rotella Capital Management first reported a position in SCMP in Q1 2014 and held it in 2 quarters. The position peaked at $240K in Q4 2014. 125 funds tracked by Wall St. Rank hold SCMP as of Q1 2015.

  • Rotella Capital Management reported no remaining Sucampo Pharmaceuticals, Inc. position as of Q1 2015 after selling out during the quarter.
  • Rotella Capital Management sold 16,798 Sucampo Pharmaceuticals, Inc. shares in Q1 2015, an estimated $240K.
  • Rotella Capital Management first reported a position in Sucampo Pharmaceuticals, Inc. in Q1 2014 and held it in 2 quarters.
  • Rotella Capital Management's Sucampo Pharmaceuticals, Inc. position peaked at $240K in Q4 2014.
  • 125 funds tracked by Wall St. Rank held Sucampo Pharmaceuticals, Inc. as of Q1 2015.

Based on Rotella Capital Management's 13F filing for Q1 2015, filed 4 May 2015.